|
|
|
|
| LEADER |
05551cam a2200685Ii 4500 |
| 001 |
on1082518939 |
| 003 |
OCoLC |
| 005 |
20210423014335.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
190117s2019 enk ob 001 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d N$T
|d OCLCF
|d YDX
|d UKMGB
|d OPELS
|d UKAHL
|d UWO
|d OCLCQ
|d S2H
|d OCLCO
|
| 015 |
|
|
|a GBB921815
|2 bnb
|
| 016 |
7 |
|
|a 019217028
|2 Uk
|
| 019 |
|
|
|a 1083034127
|
| 020 |
|
|
|a 9780128137932
|q (electronic bk.)
|
| 020 |
|
|
|a 0128137932
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128137925
|
| 020 |
|
|
|z 0128137924
|
| 035 |
|
|
|a (OCoLC)1082518939
|z (OCoLC)1083034127
|
| 050 |
|
4 |
|a RC671
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 072 |
|
7 |
|a VFM
|2 bicssc
|
| 082 |
0 |
4 |
|a 616.106
|2 23
|
| 100 |
1 |
|
|a Zabetakis, Ioannis,
|e author.
|
| 245 |
1 |
4 |
|a The impact of nutrition and statins on cardiovascular diseases /
|c Ioannis Zabetakis, Ronan Lordan, Alexandros Tsoupras.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a London, United Kingdom :
|b Academic Press,
|c [2019]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
|
|
|a Online resource; title from PDF title page (EBSCO, viewed January 29, 2019).
|
| 505 |
0 |
|
|a Intro; Title page; Table of Contents; Copyright; Dedication; Contributors; Author Biographies; Preface; Acknowledgments; Chapter 1: The Origin of Chronic Diseases With Respect to Cardiovascular Disease; Abstract; 1.1 Introduction; 1.2 Causes of Chronic Diseases Such as CVD; 1.3 Unresolved and Emerging Public Health Hazards due to Genetic, Dietary, Environmental, and Lifestyle Factors; 1.4 Concluding Remarks; Chapter 2: Inflammation; Abstract; 2.1 Inflammation; 2.2 Inflammatory Mediators; 2.3 Inflammation and Disease; 2.4 Conclusions; Chapter 3: Inflammation and Cardiovascular Diseases
|
| 505 |
8 |
|
|a Abstract3.1 Interrelation Between Inflammation, Atherosclerosis, and CVD: Moving Beyond Cholesterol, Lipoproteins, and Triglycerides; 3.2 Endothelial Dysfunction and Atherosclerosis; 3.3 Blood Cells and Cells of the Immune System in Atherosclerosis and CVD; 3.4 The Interplay and Crosstalk Between Several Inflammatory Pathways and Mediators During Atherogenesis and Atherosclerosis; The Role of Cytokines, Eicosanoids, PAF, and HDL; 3.5 Conclusion; Chapter 4: The Lipid Hypothesis and the Seven Countries Study; Abstract; 4.1 Introduction; 4.2 The Understanding of Atherosclerosis Circa 1800-1930
|
| 505 |
8 |
|
|a 4.3 Cholesterol4.4 Lipid Hypothesis: Origin, Development, and Prelude to the Seven Countries Study; 4.5 Ancel Keys (1904-2004); 4.6 Familial Hypercholesterolemia; 4.7 Concluding Remarks; Chapter 5: Cholesterol in Atherosclerosis and Cardiovascular Disease: The Role of Specific Dietary and Lifestyle Patterns; Abstract; 5.1 Introduction; 5.2 Mediterranean Diet Food Pyramid; 5.3 Applying the Mediterranean Diet in Non-Med Counties: Is It Feasible?; 5.4 French Paradox; 5.5 Blue Zones Concept; 5.6 Food for Thought; Chapter 6: Statins: Rationale, Mode of Action, and Side Effects; Abstract
|
| 505 |
8 |
|
|a 6.1 Introduction6.2 Cholesterol and Its Function in Humans; 6.3 How Did Statins Develop?; 6.4 Statin Mechanism of Action; 6.5 Pleiotropic Effects of Statin; 6.6 Statin Side Effects; 6.7 Dosage and Side Effects: Diabetes; 6.8 Current Guidelines for Patients; 6.9 Clarity on True Benefits Versus Risks; 6.10 Critical Evaluation; 6.11 Future Perspectives: Inflammation; 6.12 Conclusion; Chapter 7: Cardiovascular Risk: Assumptions, Limitations, and Research; Abstract; 7.1 Introduction; 7.2 Evaluation of CVD Risk; 7.3 Blood Pressure; 7.4 Cardiovascular Risk Assessment
|
| 505 |
8 |
|
|a 7.5 Novel and Traditional Cardiovascular Risk Factors7.6 Conclusion; Chapter 8: Diet and Cardiovascular Disease: The Mediterranean Diet; Abstract; 8.1 Introduction; 8.2 The Mediterranean Diet in Cardiovascular Disease Prevention; 8.3 Potential Mechanisms Implicated in CVD Prevention; 8.4 The Mediterranean Diet: PAF-Related Inflammatory Pathways and Metabolism; 8.5 Implementing the Mediterranean Diet Outside the Mediterranean Region; 8.6 Conclusions; Chapter 9: Nutrition Versus Statins in Primary Prevention: Where do we Stand Now?; Abstract; 9.1 Inflammation
|
| 650 |
|
0 |
|a Cardiovascular system
|x Diseases
|x Diet therapy.
|
| 650 |
|
0 |
|a Diet therapy.
|
| 650 |
|
0 |
|a Statins (Cardiovascular agents)
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Cardiovascular system
|x Diseases
|x Diet therapy.
|2 fast
|0 (OCoLC)fst00847190
|
| 650 |
|
7 |
|a Diet therapy.
|2 fast
|0 (OCoLC)fst00893321
|
| 650 |
|
7 |
|a Statins (Cardiovascular agents)
|2 fast
|0 (OCoLC)fst01132036
|
| 655 |
|
0 |
|a Electronic books.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Lordan, Ronan,
|e author.
|
| 700 |
1 |
|
|a Tsoupras, Alexandros,
|e author.
|
| 776 |
0 |
8 |
|i Print version:
|a Zabetakis, Ioannis.
|t Impact of nutrition and statins on cardiovascular diseases.
|b First edition.
|d London, United Kingdom : Academic Press, [2019]
|z 0128137924
|z 9780128137925
|w (OCoLC)1046604502
|
| 856 |
4 |
0 |
|3 ScienceDirect
|u https://www.sciencedirect.com/science/book/9780128137925
|
